MCMedicalCodingSoftware
J0615

J0615: Calcium acetate, oral, 23 mg (for esrd on dialysis)

HCPCSActiveBETOS O1E

J0615 is a HCPCS Level II code for calcium acetate, oral, 23 mg (for esrd on dialysis). It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J0615

Long descriptor
Calcium acetate, oral, 23 mg (for esrd on dialysis)

The official wording. This is what the code means.

Short descriptor
Calcium acetate, oral, 23 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2025

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
57: Other

Other carrier priced.

Codes adjacent to J0615

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J0615 is not quite right, the correct code is very often within a few positions of it.

  • J0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
  • J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
  • J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
  • J0610Injection, calcium gluconate (fresenius kabi), per 10 mlterminated
  • J0611Injection, calcium gluconate (wg critical care), per 10 mlterminated
  • J0612Injection, calcium gluconate, not otherwise specified, 10 mg
  • J0613Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
  • J0614Injection, treosulfan, 50 mg
  • J0616Injection, metoprolol tartrate, 1 mg
  • J0618Injection, calcium chloride, 2 mg
  • J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
  • J0630Injection, calcitonin salmon, up to 400 units
  • J0636Injection, calcitriol, 0.1 mcg
  • J0637Injection, caspofungin acetate, 5 mg
  • J0638Injection, canakinumab, 1 mg
  • J0640Injection, leucovorin calcium, per 50 mgterminated
HCPCS Level II2026Q4-Oct· effective October 1, 2026